There are 2949 resources available
586P - Bidirectional chemotherapy for initially unresectable malignant peritoneal mesothelioma: Proof of concept of a new conversion strategy?
Presenter: Maximiliano Gelli
Session: E-Poster Display
Resources:
Abstract
587P - Toxicity and antitumor activity of novel agents in elderly cancer patients in phase I studies
Presenter: Geriletu Ao
Session: E-Poster Display
Resources:
Abstract
588P - Analysis and adherence to the ASCO recommendations for research biopsies and archival tissue requirements in clinical trials conducted at Institut Jules Bordet (IJB) from 2015 to 2019
Presenter: Laetitia Collet
Session: E-Poster Display
Resources:
Abstract
589P - The impact of sarcopenia in patients enrolled in early phase cancer trials
Presenter: Alexandra Lewis
Session: E-Poster Display
Resources:
Abstract
590P - A double-blind, randomized, parallel group study to demonstrate the equivalent pharmacokinetic properties of a single intravenous dose HD201, a trastuzumab biosimilar candidate, versus EU trastuzumab and US trastuzumab
Presenter: Martin Demarchi
Session: E-Poster Display
Resources:
Abstract
591P - Distress and perceived information among patients in phase I trials and their relatives: A prospective study
Presenter: Katrine Gad
Session: E-Poster Display
Resources:
Abstract
592P - A predictive score of antitumour activity of novel agents in cancer patients treated in early phase studies
Presenter: Runhan Liu
Session: E-Poster Display
Resources:
Abstract
593P - Longitudinal description of clinical trials for the development of cyclin-dependent kinases inhibitors
Presenter: Claudia Cardone
Session: E-Poster Display
Resources:
Abstract
594P - The Drug Rediscovery Protocol (DRUP): Results of the first 500 treated patients
Presenter: Louisa Hoes
Session: E-Poster Display
Resources:
Abstract
595P - Abdominal events in targeted therapies: Report from the Drug Rediscovery Protocol (DRUP)
Presenter: Laurien Zeverijn
Session: E-Poster Display
Resources:
Abstract